STSA - Satsuma Pharmaceuticals GAAP EPS of -$0.52 August, 09 2022 05:30 PM Satsuma Pharmaceuticals Inc. Satsuma Pharmaceuticals press release ( NASDAQ: STSA ): Q2 GAAP EPS of -$0.52. $68.1 million in cash, cash equivalents and marketable securities as of June 30, 2022, provides runway into second half of 2023 For further details see: Satsuma Pharmaceuticals GAAP EPS of -$0.52